David L. Saltman

3.9k total citations · 1 hit paper
33 papers, 3.2k citations indexed

About

David L. Saltman is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David L. Saltman has authored 33 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David L. Saltman's work include Lung Cancer Treatments and Mutations (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). David L. Saltman is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). David L. Saltman collaborates with scholars based in United States, Canada and United Kingdom. David L. Saltman's co-authors include A. Thomas Look, Stephan W. Morris, Marcus B. Valentine, David N. Shapiro, Mark N. Kirstein, Michael L. Cleary, Jamison L. Nourse, Naomi Galili, K. Monica and Victor Stastny and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

David L. Saltman

32 papers receiving 3.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma

1994 1.9k citations Stephan W. Morris, David L. Saltman et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. Saltman United States	17	1.5k	1.1k	875	796	338	33	3.2k
Richard C. Frank United States	21	1.1k 0.7×	986 0.9×	616 0.7×	495 0.6×	236 0.7×	50	2.4k
Norihiko Kawamata Japan	38	2.2k 1.5×	1.4k 1.3×	745 0.9×	314 0.4×	610 1.8×	96	4.0k
Joan M. O’Brien United States	31	2.1k 1.4×	1.8k 1.7×	464 0.5×	440 0.6×	460 1.4×	130	5.3k
Cristina E. Tognon United States	26	2.0k 1.3×	980 0.9×	404 0.5×	509 0.6×	458 1.4×	81	3.6k
Turid Knutsen United States	23	969 0.6×	752 0.7×	359 0.4×	361 0.5×	127 0.4×	37	2.1k
David W. Goodrich United States	34	3.1k 2.0×	2.3k 2.1×	425 0.5×	1.1k 1.4×	364 1.1×	97	5.0k
Mark A. Pershouse United States	15	2.4k 1.6×	615 0.6×	433 0.5×	330 0.4×	434 1.3×	33	3.1k
Perry D. Nisen United States	31	1.8k 1.2×	870 0.8×	209 0.2×	550 0.7×	182 0.5×	55	3.0k
Tracy Chaplin United Kingdom	35	2.2k 1.5×	581 0.5×	416 0.5×	338 0.4×	687 2.0×	80	3.9k
Brian C. Lewis United States	33	3.2k 2.1×	1.2k 1.1×	344 0.4×	668 0.8×	150 0.4×	53	4.4k

Countries citing papers authored by David L. Saltman

Since Specialization

Citations

This map shows the geographic impact of David L. Saltman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Saltman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Saltman more than expected).

Fields of papers citing papers by David L. Saltman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Saltman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Saltman. The network helps show where David L. Saltman may publish in the future.

Co-authorship network of co-authors of David L. Saltman

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Saltman. A scholar is included among the top collaborators of David L. Saltman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Saltman. David L. Saltman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saltman, David L., Matthew G. Varga, Nicole S. Croteau, et al.. (2022). 27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study. Clinical Lung Cancer. 24(2). 137–144. 2 indexed citations

Hout, David R., Brock L. Schweitzer, Stephan W. Morris, et al.. (2017). Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer. Cancers. 9(8). 99–99. 23 indexed citations

Berry, Brian, et al.. (2015). Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease. BMC Research Notes. 8(1). 308–308. 8 indexed citations

Weber, Britta, Mitchell Liu, Stephan W. Morris, et al.. (2015). Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion‐positive lung cancer patient. Journal of Medical Radiation Sciences. 63(1). 67–70. 8 indexed citations

Walker, Shannon L., et al.. (2010). Awareness of Risk Factors among Persons at Risk for Lung Cancer, Chronic Obstructive Pulmonary Disease and Sleep Apnea: A Canadian Population-Based Study. Canadian Respiratory Journal. 17(6). 287–294. 23 indexed citations

MacKenzie, Mary J., David L. Saltman, Hal W. Hirte, et al.. (2007). A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium. Investigational New Drugs. 25(6). 553–558. 79 indexed citations

Durán, Ignacio, Le Liu, David L. Saltman, et al.. (2005). A phase II trial of temsirolimus in metastatic neuroendocrine carcinomas (NECs). Journal of Clinical Oncology. 23(16_suppl). 3096–3096. 4 indexed citations

Webb, Murray S., David L. Saltman, Joseph M. Connors, & James H. Goldie. (2002). A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 43(5). 975–982. 8 indexed citations

Fairman, Jeff, et al.. (1996). Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. Blood. 88(6). 2259–2266. 38 indexed citations

10.

Morris, S. W., et al.. (1995). Sequence Correction. Science. 267(5196). 316–317. 49 indexed citations

11.

Saltman, David L., Gregory Dolganov, Janet A. Warrington, John J. Wasmuth, & Michael Lovett. (1993). A Physical Map of 15 Loci on Human Chromosome 5q23-q33 by Two-Color Fluorescence in Situ Hybridization. Genomics. 16(3). 726–732. 58 indexed citations

12.

Saltman, David L., et al.. (1993). Telomeric structure in cells with chromosome end associations. Chromosoma. 102(2). 121–128. 73 indexed citations

13.

Saltman, David L., Gregory Dolganov, L.M. Hinton, & Michael Lovett. (1992). Reassignment of the human macrophage colony stimulating factor gene to chromosome 1p13-21. Biochemical and Biophysical Research Communications. 182(3). 1139–1143. 6 indexed citations

14.

Saltman, David L., et al.. (1992). Isolation of region-specific cosmids from chromosome 5 by hybridization with microdissection clones. Nucleic Acids Research. 20(6). 1401–1404. 5 indexed citations

15.

Fleischman, Roger A., David L. Saltman, Victor Stastny, & Susan Mahler Zneimer. (1991). Deletion of the c-kit protooncogene in the human developmental defect piebald trait.. Proceedings of the National Academy of Sciences. 88(23). 10885–10889. 163 indexed citations

16.

Kiefer, Michael, et al.. (1991). Identification of a Second Human Subtilisin-Like Protease Gene in the fes/fps Region of Chromosome 15. DNA and Cell Biology. 10(10). 757–769. 238 indexed citations

17.

Saltman, David L., et al.. (1990). Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; Evidence of leukemic origin by immunoglobulin gene rearrangement. Leukemia Research. 14(4). 381–387. 41 indexed citations

18.

Saltman, David L., Julia D. Mellentin, Stephen D. Smith, & Michael L. Cleary. (1990). Mapping of translocation breakpoints on the short arm of chromosome 19 in acute leukemias by in situ hybridization. Genes Chromosomes and Cancer. 2(4). 259–265. 11 indexed citations

19.

Saltman, David L., et al.. (1989). Telomeric associations in a lymphoblastoid cell line from a patient with B-cell follicular lymphoma. Cytogenetic and Genome Research. 50(4). 230–233. 17 indexed citations

20.

Pfeiffer, Carl J., Chi H. Cho, Amarjit Cheema, & David L. Saltman. (1980). Reserpine-induced gastric ulcers: Protection by lysosomal stabilization due to zinc. European Journal of Pharmacology. 61(4). 347–353. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact